Weak US sentiment hurts dietary supplement sales, offsetting broader growth, Novonesis CEO says

By Reuters News

- Novonesis NSISb.CO CEO said on Thursday that changing US consumer behaviour and weaker buying power were weighing on the North American dietary supplement market, which the biotech firm expects to return to growth only in the second half of 2027.

Revenue in Novonesis' Human Health business fell 8% in the third quarter, as a decline in North American offline dietary supplements offset growth in dietary supplements elsewhere, Ester Baiget said during a post-earnings call.

  • European peer dsm-firmenich DSFIR.AS also flagged cautious consumer behaviour in North America when it reported quarterly results earlier this week

  • Novonesis' group revenue grew 6% organically, broadly in line with a company-provided consensus

  • Revenue at its Food & Beverages division, in contrast, grew 14% in the quarter

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk